The Food and Drug Administration FDA the Agency or we is announcing the following public meeting entitled Advancing Smoking Cessation: FDA and NIH Priorities. Jointly convened by FDA and the National Institutes of Health NIH this public meeting will address the need for novel smoking cessation products to help individuals of all ages including underserved and vulnerable populations stop smoking. The overall goal of the meeting is to stimulate novel product development to reduce rates of smoking and related chronic illnesses. The meeting format will include presentations and panel discussions.